Real-World Data / Real-Word Evidence Resources
-
ISPOR 2024-2025 Top 10 HEOR Trends
5/14/2025
This report outlines ten defining HEOR trends influencing global health decision-making.
-
Unlocking The Power Of Real-World Evidence In FDA Submissions
5/15/2023
Understand the gaps between how data is collected in real-world evidence (RWE) and randomized clinical trials (RCT) and how RWE is quickly finding ways to catch up.
-
Navigating The Evolving Regulatory And Data Landscape
8/19/2024
Explore how real-world evidence is reshaping clinical research and learn why precision and innovation are key to staying ahead in this evolving landscape.
-
Executing Concurrent Decentralized RCTs And RWE At Scale
3/31/2026
See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.
-
Tracking Functional Capacity To Advance Neuromuscular Disease Research
2/6/2026
This presentation introduces a dual-endpoint approach to monitoring neuromuscular disease progression through two high-centile digital measures.
-
Optimize Your Oncology Trial Protocol With Real-World Data
9/16/2024
Set your next oncological clinical trials up for success using high-quality real-world data (RWD) to anticipate and confront potential problems early on.
-
Unlocking Real-World Insights For Transformative Clinical Outcomes
10/19/2023
Tap into a diverse, tokenized real-world dataset covering over 300 million U.S. lives and utilize longitudinal transaction-level patient data and live test/biomarker results.
-
Create Personalized Treatments With VR And RWD
5/13/2023
Dive into the ways this cutting-edge technology is revolutionizing how healthcare providers create personalized treatment plans for patients suffering from chronic low back pain (CLBP).
-
The Hidden Cost Of Preferred Vendors
10/21/2025
Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.
-
One Day, We Won't Need Placebos
11/17/2023
Embrace the future of clinical research by recognizing the limitations of traditional double-blind trials and exploring the transformative potential of real-world evidence (RWE).